Ligand Pharmaceuticals LGND
NASDAQ LGND
$306.34 -6.03 (-1.93%)
As of: Oct 1, 2026 · 2:06 PM EDT

Ligand Pharmaceuticals (LGND) Other financing activities (2016 - 2026)

Updated

Ligand Pharmaceuticals' Other financing activities came in at $345,000 for Q2 2026, up 137.9% from $145,000 a year earlier but down 98.4% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Other financing activities (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Ligand Pharmaceuticals reported Other financing activities of $28.57 million, up 157.5% year-over-year; for FY2025, it came in at $15.53 million, up 202.3% from FY2024.

  • Other financing activities carries a five-year compound annual growth rate of 60.0% (FY2020 to FY2025).
  • Going back by year, Other financing activities was $5.14 million in FY2024 (+13.0%), $4.55 million in FY2023 (-44.8%), $8.24 million in FY2022 (-56.5%) and $18.94 million in FY2021.
  • The five-year range for quarterly Other financing activities is $32,000 (Q2 2023) to $21.73 million (Q1 2026).
  • Year-over-year, Other financing activities increased in five of the last six quarters, with growth averaging 179.6%.
  • The fastest year-over-year change in Other financing activities over five years came in Q4 2024 (growth of 652.9%), and the weakest in Q3 2022 (a decline of 95.4%).
  • Business Quant data shows LGND's Other financing activities at $21.73 million (Q1 2026), $617,000 (Q4 2025) and $5.88 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 345,000.00
Mar 31, 2026 21.73 Mn
Dec 31, 2025 617,000.00
Sep 30, 2025 5.88 Mn
Jun 30, 2025 145,000.00
Mar 31, 2025 8.89 Mn
Dec 31, 2024 1.94 Mn
Sep 30, 2024 125,000.00
Mar 31, 2024 3.08 Mn
Dec 31, 2023 257,000.00
Sep 30, 2023 103,000.00
Jun 30, 2023 32,000.00
Mar 31, 2023 4.16 Mn
Dec 31, 2022 2.22 Mn
Sep 30, 2022 96,000.00
Jun 30, 2022 60,000.00
Mar 31, 2022 5.86 Mn
Sep 30, 2021 2.08 Mn
Mar 31, 2021 16.86 Mn
Dec 31, 2020 52,000.00
API Access

Ligand Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=LGND&period=max&api_key=YOUR_API_KEY